)
Imricor Medical Systems (IMR) investor relations material
Imricor Medical Systems H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved CE Mark approval for second-generation ablation catheter, NorthStar MRI-native 3D mapping system, and capital equipment in Europe under EU MDR.
Performed world-first in vivo PFA ablations and first-in-human ischemic VT ablation under real-time MRI guidance, validating the technology and field.
Expanded clinical trial footprint in the US and Europe, with new hospital sites, regulatory submissions, and VISABL-AFL trial expansion.
Commercial readiness advanced with Philips MRI platform integration, European sales team expansion, and customer pipeline growth from 7 to 40 sites.
Strengthened leadership and board to support commercialization and growth.
Financial highlights
FY 2025 revenue was $292,000, down from $959,000 year-over-year, mainly due to non-revenue-generating clinical trial procedures.
Consumable device sales fell 63% to $171,000; equipment revenues also declined.
Operating cash outflow was $19 million, up $3.5 million from the prior year, reflecting increased investment in commercial and regulatory activities.
Net loss before tax was $25.3 million, a 15% improvement from the prior year, but adjusted net loss rose 33% to $20.99 million.
Cash and marketable securities totaled $40.8 million at year-end.
Outlook and guidance
Positioned to scale commercially in Europe, Middle East, and soon the U.S. as regulatory approvals progress.
Anticipates FDA approval for U.S. commercial release of platform technology and further 510(k) submissions in the next 3–6 months.
Expects acceleration in consumable revenues and capital sales as clinical trial sites convert to commercial use.
New site activations expected in the US, ANZ, Nordics, and Middle East within 6–12 months.
VISABL-AFL trial completion and platform approval targeted for this calendar year.
Next Imricor Medical Systems earnings date
Next Imricor Medical Systems earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)